Overview

LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies

Status:
Not yet recruiting
Trial end date:
2027-01-15
Target enrollment:
Participant gender:
Summary
A study of LMP1 CAR-T for patients with LMP1 positive infectious diseases and hematological malignancies
Phase:
Early Phase 1
Details
Lead Sponsor:
Zhejiang University
Collaborator:
Yake Biotechnology Ltd.